A detailed history of Columbia Advisory Partners LLC transactions in Viatris Inc stock. As of the latest transaction made, Columbia Advisory Partners LLC holds 11,073 shares of VTRS stock, worth $142,066. This represents 0.13% of its overall portfolio holdings.

Number of Shares
11,073
Previous 12,602 12.13%
Holding current value
$142,066
Previous $133,000 3.76%
% of portfolio
0.13%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$10.32 - $12.13 $15,779 - $18,546
-1,529 Reduced 12.13%
11,073 $128,000
Q2 2024

Jul 12, 2024

BUY
$10.05 - $12.02 $126,650 - $151,476
12,602 New
12,602 $133,000
Q2 2022

Aug 03, 2022

SELL
$9.95 - $12.27 $186,413 - $229,878
-18,735 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$9.81 - $15.4 $58,889 - $92,446
6,003 Added 47.15%
18,735 $204,000
Q4 2021

Jan 25, 2022

BUY
$12.09 - $14.68 $153,929 - $186,905
12,732 New
12,732 $172,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Columbia Advisory Partners LLC Portfolio

Follow Columbia Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Advisory Partners LLC with notifications on news.